miR-331-3p Inhibits Tumor Cell Proliferation, Metastasis, Invasion by Targeting MLLT10 in Non-Small Cell Lung Cancer

References

• Lin PY, Yu SL, Yang PC. MicroRNA in lung cancer. Br J Cancer. 2010;103(8):1144–1148. doi:10.1038/sj.bjc.660590120859290
   PubMed Web of Science ®Google Scholar
• Castro D, Moreira M, Gouveia AM, Pozza DH, De Mello RA. MicroRNAs in lung cancer. Oncotarget. 2017;8(46):81679–81685. doi:10.18632/oncotarget.2095529113423
   PubMedGoogle Scholar
• Lind H, Zienolddiny S, Ryberg D, Skaug V, Phillips DH, Haugen A. Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: a possible interaction with polymorphisms in the interleukin 1 beta gene. Lung Cancer. 2005;50(3):285–290. doi:10.1016/j.lungcan.2005.07.00316126303
   PubMed Web of Science ®Google Scholar
• Goldstraw P, Ball D, Jett JR, et al. Non-small-cell lung cancer. Lancet. 2011;378(9804):1727–1740. doi:10.1016/S0140-6736(10)62101-021565398
   PubMed Web of Science ®Google Scholar
• Barger JF, Nana-Sinkam SP. MicroRNA as tools and therapeutics in lung cancer. Respir Med. 2015;109(7):803–812. doi:10.1016/j.rmed.2015.02.00625910758
   PubMed Web of Science ®Google Scholar
• Kang SM, Lee HJ. MicroRNAs in human lung cancer. Exp Biol Med. 2014;239(11):1505–1513. doi:10.1177/1535370214533887
   Web of Science ®Google Scholar
• Slaby O, Svoboda M, Michalek J, Vyzula R. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer. 2009;8:102. doi:10.1186/1476-4598-8-10219912656
   PubMed Web of Science ®Google Scholar
• Zhang WC, Liu J, Xu X, Wang G. The role of microRNAs in lung cancer progression. Med Oncol. 2013;30(3):675. doi:10.1007/s12032-013-0675-823925663
   PubMed Web of Science ®Google Scholar
• Del Vescovo V, Grasso M, Barbareschi M, Denti MA. MicroRNAs as lung cancer biomarkers. World J Clin Oncol. 2014;5(4):604–620. doi:10.5306/wjco.v5.i4.60425302165
   PubMedGoogle Scholar
• Vannini I, Fanini F, Fabbri M. MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis. Clin Biochem. 2013;46(10–11):918–925. doi:10.1016/j.clinbiochem.2013.01.02423396164
   PubMed Web of Science ®Google Scholar
• Liu X, Sempere LF, Ouyang H, et al. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest. 2010;120(4):1298–1309. doi:10.1172/JCI3956620237410
   PubMed Web of Science ®Google Scholar
• Liu L, Bi N, Wu L, et al. MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma. Mol Cancer. 2017;16(1):50. doi:10.1186/s12943-017-0620-028241836
   PubMed Web of Science ®Google Scholar
• Geng GJ, Yang YT, Jiang J, Yu XY, Fa XE. MicroRNA-30a suppresses non-small-cell lung cancer by targeting Myb-related protein B. Exp Ther Med. 2018;15(2):1633–1639. doi:10.3892/etm.2017.555929434747
   PubMed Web of Science ®Google Scholar
• Liu S, Dong H, Dai H, Liu D, Wang Z. MicroRNA-216b regulated proliferation and invasion of non-small cell lung cancer by targeting SOX9. Oncol Lett. 2018;15(6):10077–10083. doi:10.3892/ol.2018.857329928377
   PubMed Web of Science ®Google Scholar
• Liu M, Zhou K, Cao Y. MicroRNA-944 affects cell growth by targeting EPHA7 in non-small cell lung cancer. Int J Mol Sci. 2016;17:10.
   Web of Science ®Google Scholar
• Han L, Chen W, Xia Y, et al. MiR-101 inhibits the proliferation and metastasis of lung cancer by targeting zinc finger E-box binding homeobox 1. Am J Transl Res. 2018;10(4):1172–1183.29736210
   PubMed Web of Science ®Google Scholar
• Lin X, Yang Z, Zhang P, Liu Y, Shao G. miR-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2. Oncol Lett. 2016;12(1):301–306. doi:10.3892/ol.2016.457727347142
   PubMed Web of Science ®Google Scholar
• Li S, Ma Y, Hou X, et al. MiR-185 acts as a tumor suppressor by targeting AKT1 in non-small cell lung cancer cells. Int J Clin Exp Pathol. 2015;8(9):11854–11862.26617940
   PubMed Web of Science ®Google Scholar
• Morerio C, Rapella A, Tassano E, Rosanda C, Panarello C. MLL-MLLT10 fusion gene in pediatric acute megakaryoblastic leukemia. Leuk Res. 2005;29(10):1223–1226. doi:10.1016/j.leukres.2005.03.00816111539
   PubMed Web of Science ®Google Scholar
• Burillo-Sanz S, Morales-Camacho R, Vargas MT, Carrillo E, Perez-Soto I, Garcia-Lozano JR. A new rearrangement giving rise to a very rare MLL-MLLT10 fusion mRNA in an infant acute myeloid leukemia. Cancer Genet. 2015;208(3):101–102. doi:10.1016/j.cancergen.2014.10.00625475940
   PubMed Web of Science ®Google Scholar
• Peterson JF, Sukov WR, Pitel BA, et al. Acute leukemias harboring KMT2A/MLLT10 fusion: a 10-year experience from a single genomics laboratory. Genes Chromosomes Cancer. 2019;58(8):567–577. doi:10.1002/gcc.2274130707474
   PubMed Web of Science ®Google Scholar
• Naesens L, Devos H, Nollet F, Michaux L, Selleslag D. Mediastinal myeloid sarcoma with TP53 mutation preceding acute myeloid leukemia with a PICALM-MLLT10 fusion gene. Acta Haematol. 2018;140(2):97–104. doi:10.1159/00049159630227397
   PubMed Web of Science ®Google Scholar
• Brandimarte L, Pierini V, Di Giacomo D, et al. New MLLT10 gene recombinations in pediatric T-acute lymphoblastic leukemia. Blood. 2013;121(25):5064–5067. doi:10.1182/blood-2013-02-48725623673860
   PubMed Web of Science ®Google Scholar
• Othman MONEEBAK, Melo JB, Carreira IM, et al. MLLT10 and IL3 rearrangement together with a complex four-way translocation and trisomy 4 in a patient with early T-cell precursor acute lymphoblastic leukemia: A case report. Oncol Rep. 2015;33(2):625–630. doi:10.3892/or.2014.362425435396
   PubMed Web of Science ®Google Scholar
• Chen L, Ma G, Cao X, An X, Liu X. MicroRNA-331 inhibits proliferation and invasion of melanoma cells by targeting astrocyte-elevated gene-1. Oncol Res. 2018. doi:10.3727/096504018X15186047251584
   Web of Science ®Google Scholar
• Zhao D, Sui Y, Zheng X. MiR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer. Oncol Rep. 2016;35(2):1075–1082. doi:10.3892/or.2015.445026718987
   PubMed Web of Science ®Google Scholar
• Fujii T, Shimada K, Asano A, et al. MicroRNA-331-3p suppresses cervical cancer cell proliferation and E6/E7 expression by targeting NRP2. Int J Mol Sci. 2016;17(8):1351. doi:10.3390/ijms17081351
   PubMed Web of Science ®Google Scholar
• Epis MR, Giles KM, Candy PA, Webster RJ, Leedman PJ. miR-331-3p regulates expression of neuropilin-2 in glioblastoma. J Neurooncol. 2014;116(1):67–75. doi:10.1007/s11060-013-1271-724142150
   PubMed Web of Science ®Google Scholar
• Epis MR, Giles KM, Beveridge DJ, et al. miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progression. Oncotarget. 2017;8(33):55116–55134. doi:10.18632/oncotarget.1866428903407
   PubMedGoogle Scholar
• Chang RM, Yang H, Fang F, Xu JF, Yang LY. MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase. Hepatology. 2014;60(4):1251–1263. doi:10.1002/hep.2722124825302
   PubMed Web of Science ®Google Scholar
• Cao Y, Chen J, Wang D, et al. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. Oncotarget. 2015;6(35):38093–38106. doi:10.18632/oncotarget.564226497554
   PubMedGoogle Scholar
• Chen X, Luo H, Li X, et al. miR-331-3p functions as an oncogene by targeting ST7L in pancreatic cancer. Carcinogenesis. 2018;39:1006–1015. doi:10.1093/carcin/bgy07429850766
   PubMed Web of Science ®Google Scholar
• Jing X, Wu H, Cheng X, et al. MLLT10 promotes tumor migration, invasion, and metastasis in human colorectal cancer. Scand J Gastroenterol. 2018;53(8):964–971. doi:10.1080/00365521.2018.148152130102091
   PubMed Web of Science ®Google Scholar
• Fujii T, Shimada K, Tatsumi Y, Tanaka N, Fujimoto K, Konishi N. Syndecan-1 up-regulates microRNA-331-3p and mediates epithelial-to-mesenchymal transition in prostate cancer. Mol Carcinog. 2016;55(9):1378–1386. doi:10.1002/mc.2238126259043
   PubMed Web of Science ®Google Scholar
• Zhang L, Song X, Chen X, et al. Circular RNA circcactin promotes gastric cancer progression by sponging MiR-331-3p and regulating TGFBR1 Expression. Int J Biol Sci. 2019;15(5):1091–1103. doi:10.7150/ijbs.3153331182928
   PubMed Web of Science ®Google Scholar